Lincocin (Pharmacia and Upjohn Company LLC)


Welcome to the PulseAid listing for the Lincocin drug offered from Pharmacia and Upjohn Company LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.




LABELER NAME / MANUFACTURER: Pharmacia and Upjohn Company LLC
NON-PROPRIETARY NAME: lincomycin hydrochloride
SUBSTANCE NAME: LINCOMYCIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1964-12-29
END MARKETING DATE: 0000-00-00


Lincocin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLincocin from Pharmacia and Upjohn Company LLC
LABELER NAME: Pharmacia and Upjohn Company LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/mL)
START MARKETING DATE: 1964-12-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0009-0555_55529020-c122-4964-92f9-5dfdb074d3ec
PRODUCT NDC: 0009-0555
APPLICATION NUMBER: NDA050317

Other LINCOMYCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pharmacia and Upjohn Company LLCLincocin
X-GEN Pharmaceuticals, Inc.Lincomycin